Ripretinib
Back to searchMolecule Structure
Scientific Name
Ripretinib
Description of the Drug
Ripretinib is a kinase inhibitor used to treat advanced gastrointestinal stromal tumor (GIST).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14840
http://www.drugbank.ca/drugs/DB14840
Brand Name(s)
Qinlock
Company Owner(s)
Deciphera Pharmaceuticals Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Platelet-derived growth factor receptor alpha | SINGLE PROTEIN | INHIBITOR | CHEMBL2007 |
| Stem cell growth factor receptor | SINGLE PROTEIN | INHIBITOR | CHEMBL1936 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL14999718 | |
| PharmGKB | PA166270781 | |
| Human Metabolome Database | HMDB0304864 | |
| DrugBank | DB14840 | |
| PubChem: Thomson Pharma | 163637140 | |
| PubChem | 71584930 | |
| DrugCentral | 5394 | |
| ChemicalBook | CB53365156 | |
| Guide to Pharmacology | 9175 | |
| rxnorm | RIPRETINIB | QINLOCK |
